Uronast 10mg (Propiverine Hydrochloride)

Adult dose

Adults: Administer 20 mg of propiverine hydrochloride orally once daily after a meal. The dose may be adjusted according to symptoms; if the effect is inadequate and there are no safety concerns, 20 mg may be taken up to twice daily.

This medication should not be used in certain patients. It should not be administered to patients who have allergies to this drug or its components, have gastrointestinal obstruction, or have impaired gastrointestinal motility, as it may worsen symptoms. Additionally, it should not be used by patients with urinary retention, angle-closure glaucoma, myasthenia gravis, serious heart disease, liver dysfunction, or history of arrhythmia. Patients with genetic issues such as lactose intolerance should also exercise caution. This medication should be administered cautiously in patients with urinary difficulty, liver impairment, kidney impairment, Parkinson's disease, and hyperthyroidism. Caution is also needed for elderly patients or those with autonomic neuropathy, coronary artery disease, congestive heart failure, or glaucoma when using this drug. When taking this medication, serious side effects such as psychiatric symptoms, severe constipation or abdominal distension, irregular heartbeat, thrombocytopenia, kidney dysfunction, skin rash, acute glaucoma attacks, liver dysfunction, myalgia may occur, and if symptoms arise, it is essential to immediately discontinue use and consult a physician. Moreover, due to similar diseases and symptoms with bladder cancer or prostate cancer, this medication should only be used after a definitive diagnosis, and patients with lower urinary obstruction diseases such as benign prostatic hyperplasia should prioritize treatment for that condition first. This drug may cause drowsiness or dizziness, so caution is needed when driving or operating machinery. When used in conjunction with anticholinergics or specific antidepressants, antipsychotics, interactions can increase side effects, hence caution is advised. It is best not to administer this medication to pregnant women or women of childbearing potential as safety has not been established, and it is advisable for breastfeeding women to discontinue nursing while taking this medication. It is advisable not to use this medication in children as its safety has not been confirmed, and for the elderly, as liver and kidney functions may be impaired, it should be cautiously administered starting with a lower dosage. In cases of overdose, severe symptoms such as hallucinations, agitation, seizures, urinary disturbance, heart irregularities may occur; immediate medical treatment is required. This medication must be stored out of reach of children and transferring it to other containers may affect the quality of the drug, hence caution is needed.

• Hallucinations
• delusions
• paralytic ileus
• severe constipation
• abdominal distension
• palpitations
• ectopic beats
• bradycardia
• QT prolongation
• ventricular tachycardia

This drug is sensitive to air and moisture, so it should be stored in a tightly closed container. It is recommended to maintain storage temperatures between 1 to 30 degrees Celsius to ensure the safety of the drug's effectiveness.

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle